SUBFRACTIONS IN UREMIC PLASMA ULTRAFILTRATE INHIBIT CALCITRIOL METABOLISM

被引:40
作者
HSU, CH
VANHOLDER, R
PATEL, S
DESMET, RR
SANDRA, P
RINGOIR, SMG
机构
[1] STATE UNIV GHENT HOSP,DEPT MED,DIV NEPHROL,B-9000 GHENT,BELGIUM
[2] UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,DIV NEPHROL,ANN ARBOR,MI 48104
[3] STATE UNIV GHENT,DEPT ANALYT CHEM,B-9000 GHENT,BELGIUM
关键词
D O I
10.1038/ki.1991.287
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Previous study from our laboratory has demonstrated that uremic plasma ultrafiltrate suppresses both the production rate (PR) and metabolic clearance rate (MCR) of calcitriol in normal rats. To characterize the substances responsible for the suppression of the synthesis and degradation of calcitriol, we fractionated 20 ml uremic plasma ultrafiltrates into 13 fractions using high-performance liquid chromatography (HPLC) and studied the effect of each fraction on calcitriol metabolism. We measured the MCR and PR of calcitriol in normal rats after they were infused for 20 hours with each fraction dissolved in 20 ml normal saline. Using a UV absorption ahd fluorescence emission technique, several known uremic compounds were indentified as individual peaks corresponding to the fractions. We found that fractions 4. and 6 to 13 markedly reduced the MCR of calcitriol. The patterns of the MCR suppression by the HPLC fractions suggest that there were at least two groups of chemically distinguishable compounds. Infusion of a solution containing all 13 fractions of the uremic ultrafiltrate also inhibited the calcitriol synthesis. One of the 13 fractions (fraction 4, containing uric acid, xanthine, and hypoxanthine) was further fractionated into eight subfractions. Infusion of subfractions 4 to 7 markedly reduced both the PR and MCR of calcitriol. We conclude that uremic plasma ultrafiltrate contains factors that inhibit calcitriol synthesis and degradation. These substances have molecular weight less than 2,000 Daltons.
引用
收藏
页码:868 / 873
页数:6
相关论文
共 17 条
[1]   INTRAVENOUS CALCITRIOL IN THE TREATMENT OF REFRACTORY OSTEITIS FIBROSA OF CHRONIC RENAL-FAILURE [J].
ANDRESS, DL ;
NORRIS, KC ;
COBURN, JW ;
SLATOPOLSKY, EA ;
SHERRARD, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :274-279
[2]   DETERMINANTS OF SERUM 1,25(OH)2D LEVELS IN RENAL-DISEASE [J].
CHEUNG, AK ;
MANOLAGAS, SC ;
CATHERWOOD, BD ;
MOSELY, CA ;
MITAS, JA ;
BLANTZ, RC ;
DEFTOS, LJ .
KIDNEY INTERNATIONAL, 1983, 24 (01) :104-109
[3]  
CHRISTIE W, 1987, HPLC LIPIDS PRACTICA, P23
[4]  
HOLLIS BW, 1986, CLIN CHEM, V32, P2060
[5]   FACTORS INFLUENCING CALCITRIOL METABOLISM IN RENAL-FAILURE [J].
HSU, CH ;
PATEL, S .
KIDNEY INTERNATIONAL, 1990, 37 (01) :44-50
[6]   CALCITRIOL METABOLISM IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
HSU, CH ;
PATEL, S ;
BUCHSBAUM, BL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (02) :185-190
[7]   PRODUCTION AND DEGRADATION OF CALCITRIOL IN RENAL-FAILURE RATS [J].
HSU, CH ;
PATEL, S ;
YOUNG, EW ;
SIMPSON, RU .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (05) :F1015-F1019
[8]   EFFECTS OF PURINE DERIVATIVES ON CALCITRIOL METABOLISM IN RATS [J].
HSU, CH ;
PATEL, SR ;
YOUNG, EW ;
VANHOLDER, R .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (04) :F596-F601
[9]  
PATEL S, 1990, J LAB CLIN MED, V115, P69
[10]   EFFECT OF VITAMIN-D METABOLITES ON CALCITRIOL METABOLISM IN EXPERIMENTAL RENAL-FAILURE [J].
PATEL, S ;
SIMPSON, RU ;
HSU, CH .
KIDNEY INTERNATIONAL, 1989, 36 (02) :234-239